Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Molecular targets and strategies in the development of nucleic acid cancer vaccines: from shared to personalized antigens

Journal of Biomedical Science(2024)10.1186/s12929-024-01082-xSource: DataRank Database

Molecular targets and strategies in the development of nucleic acid cancer vaccines: from shared to personalized antigens is a research paper published in Journal of Biomedical Science (2024). On theSindex it has a DataRank of 0. It has been cited 20 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access20 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (1 grants)Impact (FWCI 3.08)OA: goldTopics (32)Linked Datasets (4)DataCite Reuse (4)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (12)

Yingying Hu ORCID,Hsin‐Che Huang ORCID,Hui–Hsuan Kuo ORCID,Shu‐Hong Lin ORCID,Chun-Tien Jimmy Kuo

Live enrichment

PubMed:39379923 PMC:PMC11463125 OpenAlex:https://openalex.org/W4403222247

Foundation for the National Institutes of Health

Grant: P50CA098252

FWCI

3.08

Citation Percentile

0.9%

Citation Trend

2025

2026

goldLicense: cc-by

journalhttps://jbiomedsci.biomedcentral.com/counter/pdf/10.1186/s12929-024-01082-x

GOLDhttps://doi.org/10.1186/s12929-024-01082-x

publisherhttps://jbiomedsci.biomedcentral.com/counter/pdf/10.1186/s12929-024-01082-x

publisherhttps://link.springer.com/content/pdf/10.1186/s12929-024-01082-x.pdf

publisherhttps://link.springer.com/article/10.1186/s12929-024-01082-x/fulltext.html

Fields of Study

Immunotherapy and Immune Responsesvaccines and immunoinformatics approachesCancer Immunotherapy and BiomarkersMedicineBiology

MeSH Terms

Vaccine DevelopmentAntigens, NeoplasmHumansImmunotherapyNeoplasmsNucleic AcidsCancer VaccinesPrecision Medicine

Keywords

Computational biologyCarcinogenesisCancer vaccineDNA vaccinationPersonalized medicineCancerImmune systemAntigenBiologyImmunotherapyBioinformaticsImmunologyGeneticsImmunizationDNATumor antigensmRNAClinical TrialNeoantigens

Sustainable Development Goals

SDG 0: Good health and well-being

Additional file 1 of Molecular targets and strategies in the development of nucleic acid cancer vaccines: from shared to personalized antigens

10.6084/m9.figshare.27191674.v1figshare

Additional file 1 of Molecular targets and strategies in the development of nucleic acid cancer vaccines: from shared to personalized antigens

10.6084/m9.figshare.27191674figshare

Additional file 2 of Molecular targets and strategies in the development of nucleic acid cancer vaccines: from shared to personalized antigens

10.6084/m9.figshare.27191677.v1figshare

Additional file 2 of Molecular targets and strategies in the development of nucleic acid cancer vaccines: from shared to personalized antigens

10.6084/m9.figshare.27191677figshare

Molecular targets and strategies in the development of nucleic acid cancer vaccines: from shared to personalized antigens

FAIR Checklist

Authors (12)

Funding (1 grants)

Impact

Open Access

Topics

Linked Datasets (4)

Annotations (Europe PMC)